NCT04187781

Brief Summary

Phonak Hearing Devices pass through different development and study phases. At an early stage, feasibility studies are conducted to investigate new algorithms, features and functions in an isolated manner. If the benefit is proven, their performance is then investigated regarding interdependency between all available algorithms, features and functions running in parallel in a hearing aid (pivotal/pre-validation studies) and, resulting from the pre-validation studies, they get optimized. Prior to product launch, the Phonak Hearing Systems get reviewed by a final quality control in terms of clinical trials. This is a validation study, investigating improved algorithms, features, functions and wearing comfort. This will be a clinical investigation which will be conducted mono centric at Sonova AG Headquarters based in Stäfa (Switzerland).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
13

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Nov 2019

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 11, 2019

Completed
22 days until next milestone

First Submitted

Initial submission to the registry

December 3, 2019

Completed
2 days until next milestone

First Posted

Study publicly available on registry

December 5, 2019

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 17, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 17, 2020

Completed
Last Updated

March 3, 2020

Status Verified

February 1, 2020

Enrollment Period

2 months

First QC Date

December 3, 2019

Last Update Submit

February 28, 2020

Conditions

Outcome Measures

Primary Outcomes (1)

  • Rating of the subjective comfort for the old and the new setting

    Rating of the comfort, regarding to the loudness, with the old and the new setting of the external microphone (%)

    6 weeks

Secondary Outcomes (3)

  • Evaluation of the speech intelligibility in noise

    2 weeks

  • Subjective Sound Quality rating

    6 weeks

  • Subjective rating of natural sounds

    6 weeks

Study Arms (2)

external microphone old

OTHER
Device: external microphone

external microphone new

OTHER
Device: external microphone

Interventions

External microphone is developed for direct transmission of speech into the hearing aids for better speech intelligibility, especially in noise.

external microphone newexternal microphone old

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • experienced hearing aid user
  • severe hearing loss
  • willingness and interest in testing an external microphone healthy outer ear
  • willingness to wear behind the ear hearing aids
  • Informed Consent as documented by signature

You may not qualify if:

  • the audiogram is not in the fitting range of the intended hearing aid
  • limited mobility and not in the position to attend weekly appointments in Stäfa (Switzerland)
  • participant is not able to describe experiences and hearing impressions

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Sonova AG

Stäfa, 8712, Switzerland

Location

MeSH Terms

Conditions

Hearing Loss

Condition Hierarchy (Ancestors)

Hearing DisordersEar DiseasesOtorhinolaryngologic DiseasesSensation DisordersNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
OTHER
Intervention Model
CROSSOVER
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 3, 2019

First Posted

December 5, 2019

Study Start

November 11, 2019

Primary Completion

January 17, 2020

Study Completion

January 17, 2020

Last Updated

March 3, 2020

Record last verified: 2020-02

Locations